Sabalenka Backs WTA’s Transgender Eligibility Policy at Canadian Open

World No. 1 tennis player Aryna Sabalenka endorsed the WTA’s revised transgender eligibility policy during a press conference at the Canadian Open in Montreal. The Belarusian athlete stated her backing for the controversial guidelines that have drawn criticism from transgender rights advocates and activists.

When asked about her position on the policy, Sabalenka emphasized competitive fairness as her primary concern. She explained that biological differences between men and women create inherent advantages that would undermine the integrity of women’s professional tennis if not addressed through clear rules.

The WTA’s new protocol requires players to undergo a one-time genetic screening for the SRY gene on the Y chromosome. Sabalenka indicated her willingness to comply with the testing requirement, calling it a reasonable measure to maintain equitable competition across the tour.

Sabalenka’s comments align with statements made by tennis legend Martina Navratilova, an 18-time Grand Slam champion who has been vocal in defending the WTA’s approach. Both athletes have framed the policy as essential to preserving the fundamental purpose of women’s professional sports categories.

The WTA’s decision follows years of debate within professional sports over transgender athlete eligibility policies. Sabalenka’s direct endorsement represents a prominent player’s public stance on a topic that has generated significant discussion in athletic governance.